To the full analysis
Akso Health Group stock: growth
AHGAkso Health Group reported $13.83M in revenue for fiscal 2026, down 6.4% on the prior year.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
10.4%
per year from 2015 to 2026, per share −29.3%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2021 | since 2016 | since 2015 | |
|---|---|---|---|
| Revenue | 51.1% | 1.5% | 10.4% |
| Revenue per share | −43.2% | −37.9% | −29.3% |
| Earnings | no data | no data | no data |
| Earnings per share | no data | no data | no data |
| Free cash flow | no data | no data | no data |
| Free cash flow per share | no data | no data | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2015 | $4.65M | −$350.17K | $2.36M |
| 2016 | $11.89M | $3.54M | $6.9M |
| 2017 | $22.92M | $8.57M | $7.9M |
| 2018 | $107.26M | $65.48M | $87.27M |
| 2019 | $3.7M | $5.53M | −$2.68M |
| 2020 | $6.91M | −$71.2M | −$56.18M |
| 2021 | $1.75M | −$34.83M | $10.06M |
| 2022 | $6M | −$16.85M | −$8.63M |
| 2023 | $13.18M | −$1.36M | −$3.25M |
| 2024 | $2.41M | −$9.46M | $1.35M |
| 2025 | $14.78M | −$134.98M | $1.02M |
| 2026 | $13.83M | −$18.67M | −$188.46M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 31 Mar 2026
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 8 Aug 2025)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.